Get the Stockscreener App
2.12
8.16%
0.16
After Hours:
2.17
0.05
+2.36%
Fortress Biotech Inc stock is traded at $2.12, with a volume of 926.35K.
It is up +8.16% in the last 24 hours and up +9.28% over the past month.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
See More
Previous Close:
$1.96
Open:
$2.03
24h Volume:
926.35K
Relative Volume:
4.32
Market Cap:
$62.69M
Revenue:
$80.97M
Net Income/Loss:
$-78.31M
P/E Ratio:
-0.1913
EPS:
-11.0849
Net Cash Flow:
$-129.56M
1W Performance:
+16.48%
1M Performance:
+9.28%
6M Performance:
+23.98%
1Y Performance:
+11.58%
1-Day Range:
$1.97
$2.20
1-Week Range:
$1.83
$2.20
52-Week Range:
$1.325
$2.36
Fortress Biotech Inc Stock (FBIO) Company Profile
Name
Fortress Biotech Inc
Sector
Industry
Phone
781-652-4500
Address
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Compare FBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
2.12 | 57.96M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-15-24 | Resumed | ROTH MKM | Buy |
| Aug-04-22 | Initiated | Ladenburg Thalmann | Buy |
| Oct-02-20 | Initiated | The Benchmark Company | Buy |
| Dec-18-19 | Initiated | B. Riley FBR | Buy |
| Feb-28-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
| Mar-22-17 | Initiated | JMP Securities | Mkt Outperform |
| Oct-03-16 | Initiated | ROTH Capital | Buy |
View All
Fortress Biotech Inc Stock (FBIO) Latest News
Is Fortress Biotech Inc. stock a value trapOil Prices & Technical Pattern Based Buy Signals - newsyoung.net
Fortress Biotech, Inc. (NASDAQ:FBIO) Could Be Riskier Than It Looks - simplywall.st
Fortress Biotech Posts Q2 2025 Loss Amid High Operating Costs; Market Response Remains Mixed - AInvest
Fortress Biotech Inc. stock trend outlook and recovery pathWeekly Profit Summary & Low Risk High Win Rate Picks - Newser
Fortress Biotech Inc. stock prediction for this weekJuly 2025 Outlook & Weekly Setup with High ROI Potential - Newser
Will Fortress Biotech Inc. stock go up soon2025 Fundamental Recap & Reliable Intraday Trade Alerts - Newser
Multi asset correlation models including Fortress Biotech Inc.July 2025 Market Mood & Technical Pattern Recognition Alerts - Newser
Using AI based signals to follow Fortress Biotech Inc.2025 Price Momentum & High Return Stock Watch Alerts - Newser
Fortress Biotech Inc. At Critical Juncture — Bounce or BreakdownBuy Signal & Fast Moving Trade Plans - metal.it
Chart based exit strategy for Fortress Biotech Inc.2025 Investor Takeaways & Community Consensus Picks - Newser
Fortress Biotech Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Fortress Biotech Inc.’s volatility index tracking explainedWeekly Investment Recap & Smart Investment Allocation Tips - Newser
How to build a dashboard for Fortress Biotech Inc. stock2025 Earnings Impact & Fast Gaining Stock Reports - Newser
Fortress Biotech (NASDAQ:FBIO) Share Price Passes Above 200 Day Moving Average Following Weak Earnings - Defense World
What makes Fortress Biotech Inc. stock price move sharplyJuly 2025 Catalysts & Reliable Momentum Entry Alerts - Newser
Fortress Biotech Reports Q2 2025 Results, Notable Acquisitions, and FDA Approval - AInvest
Will Fortress Biotech Inc. stock split in the near futureAnalyst Downgrade & Consistent Return Strategy Ideas - Newser
Fortress Biotech 2025 Q2 Earnings Strong Revenue Growth, Narrowed Net Loss - AInvest
Heatmap Data Shows High Activity in Fortress Biotech Inc. Sector2025 Big Picture & Weekly Breakout Stock Alerts - sundaytimes.kr
Fortress Biotech: Q2 Earnings Snapshot - Greenwich Time
Fortress Biotech's Q2 2025: A Strategic Triad of Monetization, Regulation, and Commercial Momentum Drives Shareholder Value - AInvest
Journey Medical’s Q2 2025: Emrosi Gains Traction - TipRanks
Fortress Biotech's Q2 2025 Results: Strategic Monetization and Pipeline Catalysts Signal Long-Term Value Creation Potential - AInvest
Fortress Biotech (FBIO) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Fortress Biotech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire
Key metrics from Fortress Biotech Inc.’s quarterly data2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - Newser
Tools to assess Fortress Biotech Inc.’s risk profileQuarterly Profit Review & Low Drawdown Momentum Trade Ideas - Newser
How Fortress Biotech Inc. stock performs during market volatilityBreakout Watch & High Yield Stock Recommendations - Newser
Visualizing Fortress Biotech Inc. stock with heatmapsTrade Performance Summary & Growth Focused Stock Pick Reports - Newser
Will Fortress Biotech Inc. price bounce be sustainableJuly 2025 Momentum & Accurate Trade Setup Notifications - Newser
Why Fortress Biotech Inc. stock attracts strong analyst attentionJuly 2025 Breakouts & Long Hold Capital Preservation Plans - Newser
Using Python tools to backtest Fortress Biotech Inc. strategies [Stock Surge]Trade Opportunity Analysis - Newser
Statistical indicators supporting Fortress Biotech Inc.’s strengthAI Generated Buy/Sell Signal Forecast - Newser
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire
Strategies to average down on Fortress Biotech Inc.Wealth Accumulation Outlook for Safe Investors - Newser
Will Fortress Biotech Inc. rebound enough to break evenStrategy Playbook for Risk Controlled Trades - Newser
Should you hold or exit Fortress Biotech Inc. nowDaily Equity Signal Strength Summary Report - Newser
How high can Fortress Biotech Inc. stock goSmart Entry Watchlist with Daily Analysis - Newser
Multi factor analysis applied to Fortress Biotech Inc.Free Technical Entry Strategy for Beginners - Newser
Key External Factors That Drive Fortress Biotech Inc. Stock Price MovementsRapid Trade Forecast Based on Indicators - Newser
Price action breakdown for Fortress Biotech Inc.Chart-Based Entry Confirmation for Beginners - Newser
Fortress Biotech Inc. Ranks High in Smart Money TrackerRisk Controlled Picks With Real Returns Outlined - beatles.ru
Detecting price anomalies in Fortress Biotech Inc. with AIFuture Growth Stock Forecasting Strategy - Newser
Fortress Biotech Inc Stock (FBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):